Emergency physician 🚑🚁 & Neuro #zentensivist 🧠👩🏻⚕️ #NeuroResuscitation #IPE #MedSim #WomenInMedicine Views ≠ employer’s ≠ advice
Baltimore, MD
Joined September 2012
- Tweets2.8K
- Following609
- Followers1.2K
- Likes2.1K
🧠 Do you care for patients with acute brain injuries?
🫁 What is your sedation strategy with mechanical ventilation in these patients?
Join the #NCSVJC discussion to learn more about practice variations worldwide and impact on outcomes!
#NCSVJC is about to begin! Follow us for questions posted started shortly and hourly and discuss in the replies with colleagues. Learn more about how to participate and read the article: bit.ly/4cbgleW
Katherine Sherwood relearned to paint after an ICH with resultant hemiparesis. Facility of Speech incorporated medieval seals of Solomon to promote healing and her own cerebral angiogram.
pmc.ncbi.nlm.nih.gov/article…
@MCASD #NCS2024
Standing room only at #NCS2024 session on @brain_trauma penetrating #TBI guidelines.
Long awaited with useful algorithms including tool for assessing futility. Most importantly, advocates for aggressive surgical treatment and acknowledges challenges with prognostication.
Wendy Chang retweeted
Curious what concentration mannitol those who voted yes use? Mannitol 20% & 25% both higher osmolarity versus 3% NaCl 🤔
#NCSTJC Q3: Do you choose mannitol over hypertonic saline due to access issues? ow.ly/lCpZ50RzV3O
@drdangayach
13%Yes
87%No
90 votes • Final resultsExploring Phoenix and learning about sex, gender and diversity through #SAEM24 @AWAEM @SAEM_ADIEM #SGEM scavenger hunt
Wendy Chang retweeted
#NCSTJC Q6: The authors also found that prophylactic ceftriaxone did not affect the incidence of late VAP in patients with acute brain injury. Does this finding change your clinical practice? ow.ly/YZf150QFoZU @EM_NCC
Wendy Chang retweeted
#NCSTJC Q5: The PROPHY-VAP trial found a single dose of ceftriaxone decreased the incidence of early VAP in patients with acute brain injury. Does this finding change your clinical practice? ow.ly/YZf150QFoZU @EM_NCC
Wendy Chang retweeted
#NCSTJC Q4: Do you routinely screen for antibiotic-resistant organisms in your ICU patients? If so, which organisms and in what type of patients? ow.ly/YZf150QFoZU @EM_NCC
Wendy Chang retweeted
Other resources used around the 🌏 apart from @IDSAInfo guidelines to diagnose #VAP? Join the #NCSTJC conversation 👇#IDtwitter #NeuroTwitter #TwitteRx
#NCSTJC Q3: What criteria do you use to diagnose ventilator-associated pneumonia (VAP)? ow.ly/YZf150QFoZU @EM_NCC
Do you prefer noninvasive vs invasive sampling? 🫁
Utilize biomarkers such as procalcitonin? 🩸
Use clinical decision tools like the Clinical Pulmonary Infection Score (CPIS)? 📋
#NCSTJC
#NCSTJC Q3: What criteria do you use to diagnose ventilator-associated pneumonia (VAP)? ow.ly/YZf150QFoZU @EM_NCC
Wendy Chang retweeted
#NCSTJC Q2: Do you use prolonged IV antibiotics to prevent ventilator-associated pneumonia (VAP)? ow.ly/mwog50QFkxS @EM_NCC
2%Yes
93%No
4%It depends (explain)
91 votes • Final resultsKicking off #NCSTJC with a poll ⬇️
🔹Where do you practice if you use SOD/SDD for VAP prevention?
🔹If you don't use SOD/SDD, why not?
#NCSTJC Q1: Do you use selective oropharyngeal (SOD) and digestive tract decontamination (SDD) to prevent ventilator-associated pneumonia (VAP)? ow.ly/mwog50QFkxS
@EM_NCC
13%Yes
86%No
1%It depends (explain)
76 votes • Final results#NCSTJC on @ClaireDahyot and colleagues' PROPHY-VAP trial is starting! Join us for the conversation on ventilator-associated pneumonia prevention practices in brain injury patients
Our #NCSTJC discussion on @LancetRespirMed article begins at 9 AM CT today! Discussion questions will be posted hourly; connect with colleagues & discuss findings using #NCSTJC.
📑Read the article ow.ly/eVyq50QFkxR
Moderator: Dr. Wendy Chang @EM_NCC
Wendy Chang retweeted
Our #NCSTJC discussion on @LancetRespirMed article begins at 9 AM CT today! Discussion questions will be posted hourly; connect with colleagues & discuss findings using #NCSTJC.
📑Read the article ow.ly/eVyq50QFkxR
Moderator: Dr. Wendy Chang @EM_NCC
Looking forward to a great #NCSTJC discussion tomorrow on the PROPHY-VAP trial!
@ClaireDahyot @SigLasocki @KerforneT @pf_fr @thomasgeeraerts @AsehnouneKarim @RaphaelCinotti @ylauney @BoissonMatthieu @d_frasca @olivier_mimoz @atlanrea
Join us Feb. 20 on X (formerly known as Twitter) for a discussion on @LancetRespirMed article "Ceftriaxone To Prevent Early Ventilator-Associated Pneumonia in Patients With Acute Brain Injury." Read the article ow.ly/5XxV50Qzl67 #NCSTJC
Moderator: Dr. Wendy Chang @EM_NCC
Wendy Chang retweeted
NEW research—Ceftriaxone to prevent early ventilator-associated #pneumonia in patients with #AcuteBrainInjury
From @ClaireDahyot & colleagues: bit.ly/3HzByR7
Wendy Chang retweeted
#NCSTJC This is the question. And even more importantly, once we have achieved this understanding, how will we use it to create societal change to intervene and allow for more equitable outcomes for patients with stroke and ICH.
Wendy Chang retweeted
#NCSTJC Q5: The far-reaching effects of social determinants of health (SDOH) are increasingly appreciated but still poorly understood. How can we, as a profession, better understand the impact of SDOH on individuals and populations at risk for neurocritical illness?
